News

08 Nov 2017
REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services
Press release: REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services
Read more

08 Nov 2017
Visit REPROCELL at the “North East England Life Science Showcase” in Cambridge, MA (USA) on November 30, 2017
Visit REPROCELL at the “North East England Life Science Showcase” in Cambridge, MA (USA) on November 30, 2017
Read more

07 Nov 2017
Prof Stefan Przyborski to chair and speak at SMi Group’s 3D Cell Culture 2018 Conference
REPROCELL Europe Ltd's CSO Prof Stefan Przyborski to chair and speak at SMi Group’s 3D Cell Culture 2018 Conference
Read more

More >

Testimonals

I am very pleased with our cooperation so far; nice data and very good fit to our internal knowledge of the compounds

Senior Scientist, Top 20 European Pharma

We used Biopta because they are able to provide sensitive and accurate information from a wide range of different types of tissue

CEO, UK Biotech

Biopta's human tissue services have played a critical part in our compound selection and have added considerable value to our lead compound

President & Head of R&D, Canadian Biotech
Live chat by BoldChat